Oikos Holdings’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,211
Closed -$365K 4
2018
Q3
$365K Hold
5,211
0.31% 8
2018
Q2
$387K Hold
5,211
0.24% 10
2018
Q1
$496K Hold
5,211
0.39% 9
2017
Q4
$673K Buy
+5,211
New +$673K 0.39% 8